CHF 1.3
(2.45%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 59.14 Million CHF | 65.03% |
2022 | 35.84 Million CHF | 65.03% |
2021 | 21.71 Million CHF | 68.41% |
2020 | 12.89 Million CHF | -27.12% |
2019 | 17.69 Million CHF | 66.44% |
2018 | 10.63 Million CHF | 145.75% |
2017 | -23.23 Million CHF | 0.0% |
2016 | - CHF | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 66.39 Million CHF | 11.96% |
2024 Q1 | 59.3 Million CHF | 0.27% |
2024 Q3 | 67.19 Million CHF | 1.21% |
2023 Q3 | 60.33 Million CHF | 10.6% |
2023 Q4 | 59.14 Million CHF | -1.96% |
2023 FY | 59.14 Million CHF | 65.03% |
2023 Q1 | 60.15 Million CHF | 67.85% |
2023 Q2 | 54.54 Million CHF | -9.32% |
2022 Q2 | 16.45 Million CHF | 127.81% |
2022 Q4 | 35.84 Million CHF | 90.74% |
2022 FY | 35.84 Million CHF | 65.03% |
2022 Q1 | 7.22 Million CHF | -66.73% |
2022 Q3 | 18.79 Million CHF | 14.16% |
2021 Q1 | - CHF | 0.0% |
2021 FY | 21.71 Million CHF | 68.41% |
2021 Q4 | 21.71 Million CHF | 0.0% |
2021 Q3 | - CHF | 0.0% |
2021 Q2 | - CHF | 0.0% |
2020 FY | 12.89 Million CHF | -27.12% |
2020 Q1 | - CHF | 0.0% |
2020 Q2 | - CHF | 0.0% |
2020 Q3 | - CHF | 0.0% |
2020 Q4 | - CHF | 0.0% |
2019 Q2 | - CHF | 0.0% |
2019 FY | 17.69 Million CHF | 66.44% |
2019 Q4 | - CHF | 0.0% |
2019 Q1 | - CHF | 0.0% |
2019 Q3 | - CHF | 0.0% |
2018 Q1 | - CHF | 0.0% |
2018 FY | 10.63 Million CHF | 145.75% |
2018 Q3 | - CHF | 0.0% |
2018 Q2 | - CHF | 0.0% |
2018 Q4 | - CHF | 0.0% |
2017 Q1 | - CHF | 0.0% |
2017 FY | -23.23 Million CHF | 0.0% |
2017 Q4 | - CHF | 0.0% |
2017 Q3 | - CHF | 0.0% |
2017 Q2 | - CHF | 0.0% |
2016 FY | - CHF | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Addex Therapeutics Ltd | - CHF | -Infinity% |
BB Biotech AG | -2.63 Billion CHF | 102.243% |
Basilea Pharmaceutica AG | 26.41 Million CHF | -123.953% |
Evolva Holding SA | - CHF | -Infinity% |
Kuros Biosciences AG | 4.85 Million CHF | -1117.998% |
Molecular Partners AG | - CHF | -Infinity% |
Relief Therapeutics Holding AG | 557 Thousand CHF | -10518.671% |
Santhera Pharmaceuticals Holding AG | 1.81 Million CHF | -3165.93% |